Kaiser Permanente Center for Health Research in Portland, OR.
Perm J. 2021 Dec 13;26(1):21-31. doi: 10.7812/TPP/21.056.
Implementation of a Diabetes Prevention Program (DPP) in both in-person and digital health-care settings has been increasing. The purpose of this article is to describe the protocol of a mixed-methods, natural experiment study designed to evaluate the implementation of DPP in a large, integrated health system.
Kaiser Permanente Northwest patients who were 19 to 75 years with prediabetes (hemoglobin A1c or glycated hemoglobin, 5.7-6.4) and obesity (body mass index ≥ 30 kg/m) were invited, via the Kaiser Permanente Northwest patient portal, to participate in the digital (n = 4124) and in-person (n = 2669) DPP during 2016 through 2018. Primary (weight) and secondary (hemoglobin A1c or glycated hemoglobin level) outcome data will be obtained from electronic health records. A cost-effectiveness analysis as well as qualitative interviews with patients (enrolled and not enrolled in the DPP) and stakeholders will be conducted to examine further implementation, acceptability, and sustainability.
The mixed-methods, natural experiment design we will use to evaluate Kaiser Permanente Northwest's implementation of the digital and in-person DPP builds on existing evidence related to the effectiveness of these two DPP delivery modes and will contribute new knowledge related to best practices for implementing and sustaining the DPP within large health systems over the long term.
在实体和数字医疗环境中实施糖尿病预防计划(DPP)的情况越来越多。本文的目的是描述一项混合方法、自然实验研究的方案,旨在评估 DPP 在大型综合医疗系统中的实施情况。
通过 Kaiser Permanente Northwest 患者门户,邀请年龄在 19 至 75 岁之间、患有糖尿病前期(糖化血红蛋白或糖化血红蛋白,5.7-6.4)和肥胖症(体重指数≥30kg/m)的 Kaiser Permanente Northwest 患者参加 2016 年至 2018 年期间的数字(n=4124)和实体(n=2669)DPP。主要(体重)和次要(糖化血红蛋白或糖化血红蛋白水平)结果数据将从电子健康记录中获得。将进行成本效益分析以及对患者(已注册和未注册 DPP)和利益相关者的定性访谈,以进一步研究实施、可接受性和可持续性。
我们将用于评估 Kaiser Permanente Northwest 实施数字和实体 DPP 的混合方法、自然实验设计建立在与这两种 DPP 交付模式有效性相关的现有证据基础上,并将为在大型医疗系统中长期实施和维持 DPP 的最佳实践提供新知识。